Callback Enquiry +1 514 288 1997
The Global Leader in
Residence and Citizenship by Investment

SA Webinar Series

24 and 29 November 2022, Online

SA Webinar Series

Henley & Partners cordially invites you to join our upcoming webinars where we will be discussing tax residence, emigration scenarios, and offshore investment opportunities for South Africans.

Henley & Partners and Andersen: Tax Residency and Emigration  or Just a Plan B 

Tuesday |  29 November 2022 | 08:30 CET 

Join Lisa and Andrew, as they discuss real life case studies surrounding South African clients tax residence and emigration scenarios as well as clients looking to hedge their bets and invest offshore as a Plan B, by considering a second residence or citizenship.

This webinar is one every person looking for a plan B or to emigrate needs to attend.

Panelists: 

  • Andrew Wellsted - Senior Tax Consultant at the Johannesburg Offices, Andersen
  • Lisa Czepek - Director of Private Clients at the Johannesburg Office, Henley & Partners South Africa

You can register for the webinar here.

Henley & Partners and Carrick Wealth: Investing Offshore, Residency, Citizenship and Other Benefits

Thursday | 24 November 2022 | 09:00 CET

Join Lisa and Giles as they discuss the world of offshore investment opportunities. From residency and citizenship by investment to, using offshore structures as vehicles to protect and make your investments more tax efficient.

This webinar is one every person looking to invest abroad and/or obtain a second Residence or Citizenship needs to attend.

Panelists:

  • Lisa Czepek - Director of Private Clients at the Johannesburg Office, Henley & Partners South Africa
  • Giles Maynard - Regional Manager at the Johannesburg Office Carrick Wealth

You can register for the webinar here.


REQUEST A CALLBACK

We use cookies to give you the best possible experience. Click Accept all to proceed as specified, or click Allow selection to choose the types of cookies you will accept. For more information please visit our Cookies Policy.